Racial differences in follow-up of abnormal mammography findings among economically disadvantaged women

Cancer

Volumn 115, Issue 24, 2009, Pages 5788-5797

  Adams, Swann A ^a,b   Smith, Emily R ^a,b   Hardin, James ^a   Prabhu Das, Irene ^c   Fulton, Jeanette ^d   Hebert, James R ^a,b  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b South Carolina Statewide Cancer Prevention and Control Program   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d South Carolina Comprehensive Breast Center   (United States)

Author keywords

African Americans; Breast neoplasms; Health status disparities; Mammography; Medically uninsured

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; BREAST DISEASE; BREAST TUMOR; CANCER SCREENING; CHI SQUARE TEST; CONTROLLED STUDY; DIAGNOSTIC APPROACH ROUTE; ECONOMIC ASPECT; EUROPEAN AMERICAN; FEMALE; FOLLOW UP; HUMAN; INCOME; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MORTALITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RACE DIFFERENCE; STATISTICAL SIGNIFICANCE; STUDENT T TEST; SURVIVAL; UNITED STATES;

AFRICAN AMERICANS; BREAST NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH BEHAVIOR; HUMANS; MAMMOGRAPHY; PATIENT COMPLIANCE; SOCIOECONOMIC FACTORS; UNITED STATES; VULNERABLE POPULATIONS;

EID: 73149110146     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24633     Document Type: Article

References (53)

1. Adams SA, Hebert JR, Bolick-Aldrich S, et al. Breast cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology. J S C Med Assoc. 2006;102:231-239.
2. Li CI. Racial and ethnic disparities in breast cancer stage, treatment, and survival in the United States. Ethn Dis. 2005;15:S5-S9.
3. Eley JW, Hill HA, Chen VW, et al. Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA. 1994;272:947-954.
4. Freeman HP. The meaning of race in cancer of the breast. Cancer J Sci Am. 1997;3:76-77.
5. Krieger N, Van Den Eden SK, Zava D, Okamoto A. Race/ethnicity, social class, and prevalence of breast cancer prognostic biomarkers: a study of white, black, and Asian women in the San Francisco Bay Area. Ethn Dis. 1997;7:137-149.
6. Moorman PG, Jones BA, Millikan RC, Hall IJ, Newman B. Race, anthropometric factors, and stage at diagnosis of breast cancer. Am J Epidemiol. 2001;153:284-291.
7. Rose DP, Royak-Schaler R. Tumor biology and prognosis in black breast cancer patients. Cancer Detect Prev. 2001;25:16-31.
8. El-Tamer MB, Homel P, Wait R. Is race a poor prognostic factor in breast cancer? J Am Coll Surg. 1999;189:41-45.
9. Marbella AM, Layde PM. Racial trends in age-specific breast cancer mortality rates in US women. Am J Public Health. 2001;91:118-121.
10. Aldridge ML, Daniels JL, Jukic AM. Mammograms and healthcare access among US Hispanic and non-Hispanic women 40 years and older. Fam Commun Health. 2006;29:80-88.
11. Qureshi M, Thacker HL, Litaker DG, Kippes C. Differences in breast cancer screening rates: an issue of ethnicity or socioeconomics? J Womens Health Gend Based Med. 2000;9:1025-1031.
12. Wojcik B, Spinks M. Can racial differences in breast carcinoma survival be explained by access to medical care? Cancer. 2000;88(suppl):1268-1269.
13. Sanders LC, Hardy WR, Ashford-Carroll TS, Bolick-Aldrich SW. South Carolina Cancer Facts and Figures 2001-2002. Charleston, SC: South Carolina Central Cancer Registry, Office of Public Health Statistics and Information Services, South Carolina Department of Health and Environmental Control; American Cancer Society, Southeast Division; 2001.
14. Cunningham JE, Butler WM. Racial disparities in female breast cancer in South Carolina: clinical evidence for a biological basis. Breast Cancer Res Treat. 2004;88:161-176.
15. Wojcik BE, Spinks MK, Optenberg SA. Breast carcinoma survival analysis for African American and white women in an equal-access health care system. Cancer. 1998;82:1310-1318.
16. Chen V, Correa P, Kurman R, et al. Histological characteristics of breast carcinoma in blacks and whites. Cancer Epidemiol Biomarkers Prev. 1994;3:127-135.
17. McCarthy EP, Burns RB, Coughlin SS, et al. Mammography use helps to explain differences in breast cancer stage at diagnosis between older black and white women. Ann Intern Med. 1998;128:729-736.
18. Tabar L, Fagerberg G, Chen HH, Duffy SW, Gad A. Screening for breast cancer in women aged under 50: mode of detection, incidence, fatality, and histology. J Med Screen. 1995;2:94-98.
19. Kerlikowske K, Barclay J. Outcomes of modern screening mammography. J Natl Cancer Inst Monogr. 1997;22:105-111.
20. Jones BA, Patterson EA, Calvocoressi L. Mammography screening in African-American women: evaluating the research. Cancer. 2003;97:258-272.
21. Caplan LS, Helzlsouer KJ, Shapiro S, Wesley MN, Edwards BK. Reasons for delay in breast cancer diagnosis. Prev Med. 1996;25:218-224.
22. McCarthy BD, Yood MU, Boohaker EA, Ward RE, Rebner M, Johnson CC. Inadequate follow-up of abnormal mammograms. Am J Prev Med. 1996;12:282-288.
23. McCarthy BD, Yood MU, Janz NK, Boohaker EA, Ward RE, Johnson CC. Evaluation of factors potentially associated with inadequate follow-up of mammographic abnormalities. Cancer. 1996;77:2070-2076.
24. Weinmann S, Taplin SH, Gilbert J, et al. Characteristics of women refusing follow-up for tests or symptoms suggestive of breast cancer. J Natl Cancer Inst Monogr. 2005;35:33-38.
25. Kerlikowske K. Timeliness of follow-up after abnormal screening mammography. Breast Cancer Res Treat. 1996;40:53-64.
26. Caplan LS, Schoenfeld ER, O'Leary ES, Leske MC. Breast cancer and electromagnetic fields. Ann Epidemiol. 2000;10:31-44.
27. Elmore JG, Wells CK, Howard DH, Feinstein AR. The impact of clinical history on mammographic interpretations. JAMA. 1997;277:49-52.
28. Chang S, Hulka BS, Baird DD, et al. Breast cancer survival and the timing of tumor removal during the menstrual cycle. Cancer Epidemiol Biomarkers Prev. 1997;6:881-886.
29. Kerner JF, Guirguis-Blake J, Hennessy KD, et al. Translating research into improved outcomes in comprehensive cancer control. Cancer Causes Control. 2005;16:27-40.
30. American College of Radiology. Breast Imaging Reporting and Data System (BI-RADS) Atlas. Reston, Va: American College of Radiology; 2003.
31. Fleming ID, Cooper Js, Hensen DE, et al, eds. AJCC Cancer Staging Manual. 5th ed. Philadelphia, Pa: Lippincott-Raven; 1998.
32. Williams R. A note on robust variance estimation for cluster-correlated data. Biometrics. 2000;56:645-646.
33. Lin DY, Wei LJ. The robust inference for the Cox proportional hazards model. J Am Stat Assoc. 1989;84:1074-1078.
34. Caplan LS, Helzlsouer KJ, Shapiro S, Freedman LS, Coates RJ, Edwards BK. System delay in breast cancer in whites and blacks. Am J Epidemiol. 1995;142:804-812.
35. Garbers S, Jessop DJ, Foti H, Uribelarrea M, Chiasson MA. Barriers to breast cancer screening for low-income Mexican and Dominican women in New York City. J Urban Health. 2003;80:81-91.
36. Hyndman JC, Holman CD, Dawes VP. Effect of distance and social disadvantage on the response to invitations to attend mammography screening. J Med Screen. 2000;7:141-145.
37. van Ryn M, Burke J. The effect of patient race and socioeconomic status on physicians' perceptions of patients. Soc Sci Med. 2000;50:813-828.
38. Zapka JG, Puleo E, Taplin SH, et al. Processes of care in cervical and breast cancer screening and follow-up - the importance of communication. Prev Med. 2004;39:81-90.
39. Cardenosa G, Eklund GW. Rate of compliance with recommendations for additional mammographic views and biopsies. Radiology. 1991;181:359-361.
40. Mandelblatt J, Traxler M, Lakin P, et al. Breast and cervical cancer screening of poor, elderly, black women: clinical results and implications. Harlem Study Team. Am J Prev Med. 1993;9:133-138.
41. O'Malley AS, Sheppard VB, Schwartz M, Mandelblatt J. The role of trust in use of preventive services among low-income African-American women. Prev Med. 2004;38:777-785.
42. Jones BA, Dailey A, Calvocoressi L, et al. Inadequate follow-up of abnormal screening mammograms: findings from the race differences in screening mammography process study (United States). Cancer Causes Control. 2005;16:809-821.
43. Schneider AE, Davis RB, Phillips RS. Discussion of hormone replacement therapy between physicians and their patients. Am J Med Qual. 2000;15:143-147.
44. Yabroff KR, Breen N, Vernon SW, Meissner HI, Freedman AN, Ballard-Barbash R. What factors are associated with diagnostic follow-up after abnormal mammograms? Findings from a US national survey. Cancer Epidemiol Biomarkers Prev. 2004;13:723-732.
45. Caplan LS, May DS, Richardson LC. Time to diagnosis and treatment of breast cancer: results from the National Breast and Cervical Cancer Early Detection Program, 1991-1995. Am J Public Health. 2000;90:130-134.
46. Gotay CC, Wilson ME. Social support and cancer screening in African American, Hispanic, and Native American women. Cancer Pract. 1998;6:31-37.
47. Katz SJ, Hofer TP. Socioeconomic disparities in preventive care persist despite universal coverage. Breast and cervical cancer screening in Ontario and the United States. JAMA. 1994;272:530-534.
48. Harris DM, Miller JE, Davis DM. Racial differences in breast cancer screening, knowledge and compliance. J Natl Med Assoc. 2003;95:693-701.
49. Howard DL, Penchansky R, Brown MB. Disaggregating the effects of race on breast cancer survival. Fam Med. 1998;30:228-235.
50. Reisch LM, Barton MB, Fletcher SW, Kreuter W, Elmore JG. Breast cancer screening use by African Americans and whites in an HMO. J Gen Intern Med. 2000;15:229-234.
51. Zackrisson S, Andersson I, Manjer J, Janzon L. Non-attendance in breast cancer screening is associated with unfavourable socio-economic circumstances and advanced carcinoma. Int J Cancer. 2004;108:754-760.
52. Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999;353:1119-1126.
53. Smith ER, Adams SA, Prabhu-Das I, Bottai M, Fulton J, Hebert JR. Breast cancer survival among economically disadvantaged women: the influences of delayed diagnosis and treatment on mortality. Cancer Epidemiol Biomarkers Prevent. 2008;17:2882-2890.